[HTML][HTML] Circulating microRNAs as emerging regulators of COVID-19

Y Liang, D Fang, X Gao, X Deng, N Chen, J Wu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives

H Raeisi, M Noori, M Azimirad, SR Mohebbi… - Gut Pathogens, 2023 - Springer
Clostridioides difficile, which causes life-threatening diarrheal disease, is considered an
urgent threat to healthcare setting worldwide. The current standards of care solely rely on …

Gut microbiota in patients with COVID-19 and type 2 diabetes: A culture-based method

P Petakh, N Kobyliak, A Kamyshnyi - Frontiers in Cellular and Infection …, 2023 - frontiersin.org
Background The global pandemic of coronavirus disease 2019 (COVID-19) continues to
affect people around the world, with one of the most frequent comorbidities being Type 2 …

[HTML][HTML] Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective

H Raeisi, M Azimirad, A Nabavi-Rad… - Frontiers in …, 2022 - frontiersin.org
Clostridioides difficile (C. difficile), known as the major cause of antibiotic-associated
diarrhea, is regarded as one of the most common healthcare-associated bacterial infections …

The impact of clostridioides difficile infection in hospitalized patients: what changed during the pandemic?

A Boeriu, A Roman, D Dobru, M Stoian, S Voidăzan… - Diagnostics, 2022 - mdpi.com
(1) Background: Clostridioides difficile (C. difficile) and SARS-CoV-2 coronavirus represent
significant health threats. Our study focused on the impact of concurrent infections on patient …

Diarrhea and coronavirus disease 2019 infection

DM Friedel, MS Cappell - Gastroenterology Clinics, 2023 - gastro.theclinics.com
Methods The relevant literature was reviewed using two independent computer search
engines, PubMed and Ovid. The literature review was continuously updated until nearly …

Incidence and Risk Factors for Clostridioides difficile Infections in Non-COVID and COVID-19 Patients: Experience from a Tertiary Care Hospital

L Markovic-Denic, V Nikolic, B Toskovic, M Brankovic… - Microorganisms, 2023 - mdpi.com
(1) Background: The aim of this study was to assess the incidence and the risk factors for
healthcare-associated Clostridioides difficile infection (HA-CDI) in patients with COVID-19 …

Clostridioides Difficile Infection before and during Coronavirus Disease 2019 Pandemic—Similarities and Differences

N Kovačević, V Petrić, M Pete, M Popović… - Microorganisms, 2022 - mdpi.com
The aim of this study was to investigate the differences of Clostridioides difficile infection
(CDI) during the COVID-19 pandemic compared to the pre-COVID-19 era. CDI patients …

The role of gut dysbiosis in the loss of intestinal immune cell functions and viral pathogenesis

F Fakharian, S Thirugnanam, DA Welsh, WK Kim… - Microorganisms, 2023 - mdpi.com
The gut microbiome plays a critical role in maintaining overall health and immune function.
However, dysbiosis, an imbalance in microbiome composition, can have profound effects on …

[HTML][HTML] Особенности состояния кишечника на фоне новой коронавирусной инфекции

ТБ Топчий, МД Ардатская, ЛИ Буторова… - Терапевтический …, 2022 - cyberleninka.ru
Инфекция COVID-19 может проявляться поражением органов желудочно-кишечного
тракта у 25% пациентов. Одним из органов-мишеней вируса SARS-CoV-2 является …